J. B. Chemicals and Pharmaceuticals Overview
- Year Founded
-
1976
- Status
-
Public
- Employees
-
5,020
- Stock Symbol
-
506943
- Investments
-
9
- Share Price
-
$17.51
- (As of Friday Closing)
J. B. Chemicals and Pharmaceuticals General Information
Description
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.
Contact Information
- Cnergy IT Park, Unit A2, 3rd Floor & Unit A, 8th Floor
- Appa Saheb Marathe Marg, Prabhadevi
- Mumbai, 400025
- India
J. B. Chemicals and Pharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $17.51 | $17.48 | $11.03 - $18.49 | $2.71B | 155M | 6.4K | $0.38 |
J. B. Chemicals and Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 |
|---|---|---|---|---|
| EV | 2,797,007 | 1,875,429 | 1,509,510 | 1,256,721 |
| Revenue | 405,065 | 392,200 | 325,368 | 274,533 |
| EBITDA | 101,487 | 87,884 | 78,204 | 90,151 |
| Net Income | 59,140 | 51,039 | 51,721 | 60,210 |
| Total Assets | 456,591 | 432,866 | 343,856 | 304,730 |
| Total Debt | 54,126 | 69,725 | 7,195 | 6,125 |
J. B. Chemicals and Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
J. B. Chemicals and Pharmaceuticals Comparisons
Industry
Financing
Details
000000
000 00
J. B. Chemicals and Pharmaceuticals Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Indoco Remedies | Corporation | Mumbai, India | 0000 | 000.00 | 00000000 | 000.00 |
| 000 000000 | Corporation | Bangalore, India | 000 | 00000000 | ||
| 000000 | Private Equity-Backed | Pune, India | 0000 | 00.000 | 00000000 | 00.000 |
J. B. Chemicals and Pharmaceuticals Patents
J. B. Chemicals and Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2010360967-B2 | Nicotine containing formulation | Active | 16-Sep-2010 | 0000000000 | |
| AU-2010360967-A1 | Nicotine containing formulation | Active | 16-Sep-2010 | 0000000000 | |
| CA-2782734-C | Nicotine containing formulation | Active | 16-Sep-2010 | 0000000000 | |
| CA-2782734-A1 | Nicotine containing formulation | Active | 16-Sep-2010 | 0000000000 | |
| EP-2496083-A1 | Nicotine containing formulation | Inactive | 16-Sep-2010 | A61K31/465 |
J. B. Chemicals and Pharmaceuticals Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Nikhil Chopra | Chief Executive Officer & Board Member | ||
| Lakshay Kataria | Chief Financial Officer | ||
| Jason D'souza | Vice President, Investor Relations |
J. B. Chemicals and Pharmaceuticals Board Members (16)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 000000 | J. B. Chemicals and Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| 000000 0000000 | J. B. Chemicals and Pharmaceuticals | Chairman | 000 0000 |
J. B. Chemicals and Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
J. B. Chemicals and Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
J. B. Chemicals and Pharmaceuticals Investments & Acquisitions (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Glenmark Pharmaceuticals (Razel) | 22-Dec-2022 | 0000000000 | 000.00 | Pharmaceuticals | 000000 00 |
| Dr. Reddy's Laboratories (Four Paediatric Brands) | 30-Jun-2022 | 000000000 | 000.00 | Buildings and Property | |
| Biotech Laboratories | 01-Jun-2022 | 000000000 | Distributors/Wholesale | 000000 00 | |
| Novartis (Azmarda) | 01-Apr-2022 | 0000000000 | 000.00 | Buildings and Property | |
| Sanzyme (Probiotic and Reproductive Brands) | 02-Feb-2022 | Corporate Asset Purchase | 000.00 | Buildings and Property | 000000 00 |
J. B. Chemicals and Pharmaceuticals Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Biotech Laboratories | Distributors/Wholesale | Midrand, South Africa | 0000 |
J. B. Chemicals and Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated March, 31, 2023
27.15 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile
Pharmaceuticals
Industry
00 of 884
Rank
Percentile
Pharmaceuticals
Subindustry
00 of 418
Rank
Percentile
J. B. Chemicals and Pharmaceuticals Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| HBS Pharma SEZ | 08-Oct-2007 | 00000 0000000 | Completed |
|